Related Experiment Videos
Synthesis and properties of dextran-linked ampicillin
Drug Development and Industrial Pharmacy
|March 15, 2001
Summary
Dextran-linked ampicillin shows improved solubility and longer plasma half-life in rats compared to free ampicillin. This novel drug conjugate maintains comparable antibacterial activity, offering potential therapeutic advantages.
Area of Science:
- Pharmacology
- Bioconjugation Chemistry
- Drug Delivery Systems
Background:
- Free ampicillin has limitations in solubility and plasma persistence.
- Developing drug delivery systems can enhance antibiotic efficacy and pharmacokinetic profiles.
Purpose of the Study:
- To synthesize and characterize ampicillin coupled to dextran.
- To evaluate the pharmacokinetic and antibacterial properties of dextran-linked ampicillin.
Main Methods:
- Ampicillin was conjugated to dextran (MW 9,000 and 81,200) using the cyanogen bromide method.
- Varying reactant ratios controlled the degree of substitution (DSG).
- Solubility, plasma concentrations, half-life in rats, and antibacterial activity (cup-plate method) were assessed.
Main Results:
- Dextran-linked ampicillin exhibited increased water solubility compared to free ampicillin.
- Intravenous administration in rats showed higher plasma concentrations and a two-fold longer plasma half-life for dextran-linked ampicillin, particularly with higher molecular weight dextran.
- Antibacterial activity against Staphylococcus aureus, Bacillus substillis, and Escherichia coli was comparable to free ampicillin.
Conclusions:
- Dextran conjugation enhances ampicillin's pharmacokinetic properties, including solubility and plasma half-life.
- Dextran-linked ampicillin retains significant antibacterial efficacy.
- This approach represents a promising strategy for improving ampicillin-based therapies.